Insulin Lispro: all 130 studies that test it
Page 2 of 2. Open to participants first (4), then studies with results posted, then the rest; newest registration first within each.
- A Trial Investigating the Continuous Subcutaneous Insulin Infusion of a Liquid Formulation of BioChaperone Insulin Lispro in Comparison to Humalog®CompletedNCT02562313Phase 1
- To Investigate the Efficacy and Safety of Individualized Doses of BioChaperone Insulin Lispro in Comparison to Humalog® U-100 in Patients With Type 1 Diabetes MellitusCompletedNCT02528396Phase 1
- Single Dose Clamp Study to Evaluate Concentration-time Profile and Metabolic Activity of 3 Dose Levels of Afrezza and 3 Dose Levels of Insulin Lispro in Patients With Type 1 Diabetes MellitusCompletedNCT02470637Phase 1
- Blood Glucose Control With BioChaperone Insulin Lispro Compared to Insulin Lispro (Humalog®) After Ingestion of a Standardized MealCompletedNCT02344992Phase 1
- Normal Versus Dual Wave Insulin Bolus for High-protein FoodCompletedNCT02276859Phase 4
- Insulin Bolus Required for High Fat Foods in Type 1 DiabetesCompletedNCT02248454Not applicable
- A Trial to Compare the PK and PD of Insulin Lispro Administered Into Different Tissues in Subjects With Diabetes Mellitus Type 1CompletedNCT02221323Phase 2
- A Double-blinded, Randomised, Three-period Crossover Euglycaemic Clamp Trial Investigating the Pharmacokinetics, Glucodynamics and Safety of BioChaperone Human Insulin, Human Insulin (Huminsulin® Normal) and Insulin Lispro (Humalog®) in Subjects With Type 1 DiabetesCompletedNCT02213146Phase 1/2
- Humalog or Humulin for Intensive Insulin Therapy in Intensive Care UnitCompletedNCT02165566Phase 4
- A Double-blinded, Randomised, Two -Period Crossover Euglycemic Clamp Trial Investigating the Pharmacokinetics, Glucodynamics and Safety of BioChaperone Insulin Lispro and Insulin Lispro (Humalog®) in Subjects With Type 1 DiabetesCompletedNCT02029924Phase 1
- Safety and Efficacy Study of Correcting Hyperglycemia in Patients With Diabetes Having Out-patient SurgeryWithdrawnNCT01971047Phase 4
- A Study of LY2605541 and Insulin Lispro Mixture in Healthy ParticipantsCompletedNCT01871493Phase 1
- Pharmacokinetic and Injection Site Toleration of BIOD-238 and BIOD-250 Compared to Humalog® in Subjects With Type 1 DiabetesCompletedNCT01811849Phase 1
- Absorption of Insulin Following Subcutaneous Bolus Administration With Different Bolus DurationsCompletedNCT01792323Phase 1
- Effect of Short-Term Intensive Insulin Sequential Exenatide Therapy in Newly Diagnosed Type 2 Diabetic PatientsCompletedNCT01776788Phase 4
- Comparator Trial Using Insulin Glulisine vs. Insulin Lispro for Treatment of Gestational DiabetesCompletedNCT01662921Phase 2
- Efficacy of Pulsatile IV Insulin on Cognition and Amyloid Burden in Patients With Alzheimer's DiseaseWithdrawnNCT01636596Not applicable
- Comparative Bioequivalence Study of Wockhardt's Insulin Analogue Mixture Listro Mix 75/25® and Humalog Mix75/25 ® in Healthy SubjectsWithdrawnNCT01400802Phase 1
- Comparative Bioequivalence Study of Wockhardt's Insulin Analogue Listro Mix 50/50® and Humalog Mix50/50® in Healthy SubjectsWithdrawnNCT01400789Phase 1
- Comparative Bioequivalence Study of Wockhardt's Insulin Analogue Lispro (Listro™) With Humalog® in Healthy SubjectsWithdrawnNCT01399255Phase 1
- Immunogenicity Study of Wockhardt's Insulin Lispro/Lispro Mix Basal Bolus Regimen in Type 1 DiabeticsWithdrawnNCT01398670Phase 3
- A Study Evaluating the Bioequivalence of VIAject®7 Compared to VIAject®25 and Comparing the Pharmacokinetic and Pharmacodynamic Properties of VIAject®7 to Insulin Lispro in Subjects With Type 1 Diabetes MellitusCompletedNCT01235039Phase 1/2
- To Evaluate the Effect on Post-prandial Glycemia Safety, and Tolerability of Viaject 7 vs. Lispro Insulin During Subcutaneous Insulin Pump TherapyCompletedNCT01110746Phase 3
- A Study Comparing the Pharmacodynamic Properties of Insulin VIAJECT™, Regular Human Insulin, and Insulin LisproCompletedNCT01000922Phase 2
- Insulin Therapy in the Hospital Comparing Two ProtocolsCompletedNCT00841919Phase 4
- Dose-Ranging, Pharmacokinetic (PK), Glucodynamic (GD), Safety and Tolerability Study of Subcutaneously (SC) Administered Humulin R and Humalog With or Without rHuPH20CompletedNCT00803972Phase 1
- Feasibility Study of the Effect of Intra-Dermal Insulin Injection on Blood Glucose Levels After EatingCompletedNCT00553488Phase 2
- Lyspro Insulin vs Regular Insulin in Cirrhotic PatientsCompletedNCT00513201Phase 4
- Safety and Efficacy of NovoLog vs. Humalog in Insulin Pumps in Children and AdolescentsCompletedNCT00097071Phase 3
- Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric PopulationCompletedNCT00071448Phase 3